Bartosz Wojtas is an expert in Oncology at Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (Poland). As of September 2026, ScienceLeadR ranks Bartosz Wojtas in the top 1% of experts in Poland for Glioma. Bartosz Wojtas has authored 102 publications, the most recent in 2026. SLR score: 261 (community average: 125). How the SLR is computed.

LeadR Profile

261 ScienceLeadR Reputation 261
Network Map

Oncology

Subspecialties: Psychiatry - Biochemistry - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 102

Citations

Citations: 2 192 1st author: 6 Last author: 8 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cerebrospinal Fluid miRNA Profiling as a Potential Liquid Biopsy for Vestibular Schwannomas.
PMID 42776741 — micrornas, neoplasms, biopsy, neuroma, acoustic, tissues, liquid biopsy, neurilemmoma
Noncoding RNA20260
Microglia up‑regulate thromboxane A2 synthesis genes in response to C6 glioma‑conditioned medium.
PMID 42370614 — microglia, cells, genes, glioma, neoplasms, culture media, conditioned, immunity, neurophysiology, therapeutics, thromboxane a2, gene expression, thromboxanes
Acta Neurobiol Exp (Wars)20260
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate.
PMID 42345356 — cells, hematology, microscopy, electron, scanning transmission, 5' untranslated regions, stem cells, alternative splicing, spliceosomes, hematopoietic stem cells, rna
Blood20261
Chitinase-3-like protein 1 depletion in glioma cells alters tumor microenvironment and normalizes neovasculature in human glioma xenografts.
PMID 41540445 — cells, glioma, neoplasms, cell communication, chitinase-3-like protein 1, chitinases, heterografts, tumor microenvironment
Cell Commun Signal20260
TP53 mutations as drivers of chordoma progression and hallmarks of aggressive chordoma.
PMID 41420192 — chordoma, nervous system diseases, mutation, prognosis
Acta Neuropathol Commun20250

LeadR Networks

Main global connection map